Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GH and GnRH Agonist in Acquired Hypothyroidism
NCT00206375Phase 4Terminated
- Sponsor
- Baylor College of Medicine
- Start
- May 2003
- Primary completion
- Sep 2011
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of somatropin and leuprolide in acquired hypothyroidism (AH) (3 arms), sponsored by Baylor College of Medicine. Primary endpoint: Final Height. Started May 2003; status: terminated.
02
Drugs
somatropinleuprolide
03
Conditions
acquired hypothyroidism (AH)
Beyond the preview
Go deeper on NCT00206375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00206375.